Michelle Rohde

1.0k total citations
12 papers, 835 citations indexed

About

Michelle Rohde is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, Michelle Rohde has authored 12 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Physiology and 5 papers in Genetics. Recurrent topics in Michelle Rohde's work include Virus-based gene therapy research (5 papers), CRISPR and Genetic Engineering (5 papers) and Lysosomal Storage Disorders Research (5 papers). Michelle Rohde is often cited by papers focused on Virus-based gene therapy research (5 papers), CRISPR and Genetic Engineering (5 papers) and Lysosomal Storage Disorders Research (5 papers). Michelle Rohde collaborates with scholars based in United States and Canada. Michelle Rohde's co-authors include Fengrong Yan, Eliezer Masliah, Gui-Qiu Yu, Carol Lin, Lennart Mucke, Tony Wyss‐Coray, Lisa McConlogue, Michael C. Holmes, Philip D. Gregory and Shangzhen Zhou and has published in prestigious journals such as Nature Medicine, Blood and Molecular Therapy.

In The Last Decade

Michelle Rohde

11 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle Rohde United States 6 435 414 269 186 85 12 835
Parham Nejad United States 9 583 1.3× 248 0.6× 324 1.2× 91 0.5× 167 2.0× 18 1.0k
Stephanie García United States 15 385 0.9× 310 0.7× 143 0.5× 98 0.5× 43 0.5× 19 809
Regina H. Reynolds United Kingdom 12 341 0.8× 137 0.3× 164 0.6× 62 0.3× 99 1.2× 26 741
David B. Wang United States 14 369 0.8× 145 0.4× 94 0.3× 120 0.6× 27 0.3× 16 673
Gu Zhu United States 9 827 1.9× 178 0.4× 234 0.9× 36 0.2× 126 1.5× 11 1.1k
Margaret Wong United States 14 797 1.8× 140 0.3× 110 0.4× 123 0.7× 54 0.6× 27 1.3k
Jessica Dalsing-Hernandez United States 6 137 0.3× 197 0.5× 266 1.0× 40 0.2× 151 1.8× 6 577
Tuula Manninen Finland 13 685 1.6× 410 1.0× 390 1.4× 128 0.7× 372 4.4× 16 1.3k
Lauren Fong United States 8 743 1.7× 255 0.6× 62 0.2× 134 0.7× 30 0.4× 14 1.0k
Doris Lambracht‐Washington United States 17 179 0.4× 355 0.9× 256 1.0× 31 0.2× 295 3.5× 40 864

Countries citing papers authored by Michelle Rohde

Since Specialization
Citations

This map shows the geographic impact of Michelle Rohde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Rohde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Rohde more than expected).

Fields of papers citing papers by Michelle Rohde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Rohde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Rohde. The network helps show where Michelle Rohde may publish in the future.

Co-authorship network of co-authors of Michelle Rohde

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Rohde. A scholar is included among the top collaborators of Michelle Rohde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Rohde. Michelle Rohde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Pan, Yonghua, et al.. (2023). A sensitive AAV transduction inhibition assay assists evaluation of critical factors for detection and concordance of pre-existing antibodies. Molecular Therapy — Methods & Clinical Development. 31. 101126–101126. 8 indexed citations
2.
Rohde, Michelle & Kirsten Mönkemöller. (2022). Können Resilienz und Selbstwirksamkeit Therapieelemente in der Behandlung chronisch kranker Kinder und Jugendlicher sein?. Arthritis und Rheuma. 42(6). 389–396.
3.
Ou, Li, Russell C. DeKelver, Michelle Rohde, et al.. (2018). ZFN-Mediated In Vivo Genome Editing Corrects Murine Hurler Syndrome. Molecular Therapy. 27(1). 178–187. 64 indexed citations
4.
Laoharawee, Kanut, Russell C. DeKelver, Kelly M. Podetz-Pedersen, et al.. (2018). Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing. Molecular Therapy. 26(4). 1127–1136. 91 indexed citations
5.
DeKelver, Russell C., Li Ou, Kanut Laoharawee, et al.. (2017). ZFN-mediated in vivo genome editing results in phenotypic correction in murine MPS I and MPS II models. Molecular Genetics and Metabolism. 120(1-2). S41–S41. 1 indexed citations
6.
Ou, Li, Russell C. DeKelver, Susan Tom, et al.. (2016). 485. ZFN-Mediated Liver-Targeting Gene Therapy Corrects Systemic and Neurological Disease of Mucopolysaccharidosis Type I. Molecular Therapy. 24. S192–S193. 1 indexed citations
7.
Laoharawee, Kanut, Russell C. DeKelver, Susan Tom, et al.. (2016). 484. In Vivo Zinc-Finger Nuclease Mediated Iduronate-2-Sulfatase (IDS) Target Gene Insertion and Correction of Metabolic Disease in a Mouse Model of Mucopolysaccharidosis Type II (MPS II). Molecular Therapy. 24. S192–S192. 1 indexed citations
8.
DeKelver, Russell C., Michelle Rohde, Susan Tom, et al.. (2015). ZFN-mediated genome editing of albumin “safe harbor” in vivo results in supraphysiological levels of human IDS, IDUA and GBA in mice. Molecular Genetics and Metabolism. 114(2). S36–S36. 3 indexed citations
9.
Wechsler, Thomas, Michelle Rohde, Susan Tom, et al.. (2015). 479. ZFN-Mediated In Vivo Genome Editing Results in Supraphysiological Levels of Lysosomal Enzymes Deficient in Hunter and Hurler Syndrome and Gaucher Disease. Molecular Therapy. 23. S190–S190. 2 indexed citations
10.
Anguela, Xavier M., Rajiv P. Sharma, Yannick Doyon, et al.. (2013). Robust ZFN-mediated genome editing in adult hemophilic mice. Blood. 122(19). 3283–3287. 132 indexed citations
11.
Charboneau, Aubri, Lucy East, Niveen Mulholland, Michelle Rohde, & Nancy Boudreau. (2005). Pbx1 is required for Hox D3-mediated angiogenesis. Angiogenesis. 8(4). 289–296. 36 indexed citations
12.
Wyss‐Coray, Tony, Carol Lin, Fengrong Yan, et al.. (2001). TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice. Nature Medicine. 7(5). 612–618. 496 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Parham Nejad Breakdown of academic impact, for papers by Stephanie García Breakdown of academic impact, for papers by Regina H. Reynolds Breakdown of academic impact, for papers by David B. Wang Breakdown of academic impact, for papers by Gu Zhu Breakdown of academic impact, for papers by Margaret Wong Breakdown of academic impact, for papers by Jessica Dalsing-Hernandez Breakdown of academic impact, for papers by Tuula Manninen Breakdown of academic impact, for papers by Lauren Fong Breakdown of academic impact, for papers by Doris Lambracht‐Washington
Rankless by CCL
2026